DKK1 and prostate carcinoma: Further validation using sandwich ELISA assays confirmed significant downregulation of VEGF, and significant downregulation of the secreted Wnt inhibitor Dickkopf-1 (DKK-1), which is upregulated in the serum of prostate cancer patients and linked to poor survival (Rachner et al.